Cargando…

Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis

Avian-origin H5/H7 influenza has the potential to cause the next influenza pandemic. Availability of effective vaccines is an essential part of pre-pandemic preparedness. However, avian influenza surface antigens are poorly immunogenic to humans, which necessitates the use of adjuvants to augment th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Ju, Shih, Yun-Jui, Chen, Chang-Hsun, Fang, Chi-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065440/ https://www.ncbi.nlm.nih.gov/pubmed/30061656 http://dx.doi.org/10.1038/s41598-018-29858-w

Ejemplares similares

Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis
por: Lin, Yu-Ju, et al.
Publicado: (2020)

Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes
por: Powell, Bradford S., et al.
Publicado: (2015)

Evaluation of Thimerosal Removal on Immunogenicity of Aluminum Salts Adjuvanted Recombinant Hepatitis B Vaccine
por: Mahboubi, Arash, et al.
Publicado: (2012)

Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures
por: Fortpied, Juliette, et al.
Publicado: (2018)

Biopersistence and Brain Translocation of Aluminum Adjuvants of Vaccines
por: Gherardi, Romain Kroum, et al.
Publicado: (2015)

Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components
por: Otto, Robert B.D., et al.
Publicado: (2015)

GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Aluminum Adjuvants—‘Back to the Future’
por: Laera, Donatello, et al.
Publicado: (2023)

Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice
por: Hartmann, Wiebke, et al.
Publicado: (2022)

Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants
por: Stillman, Zachary S., et al.
Publicado: (2023)

Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines
por: Bo, Cunpei, et al.
Publicado: (2023)

Adjuvanted influenza vaccine dynamics
por: Parra-Rojas, César, et al.
Publicado: (2019)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients †
por: Vajo, Zoltan, et al.
Publicado: (2021)

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010)

Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants
por: HogenEsch, Harm
Publicado: (2013)

Resiquimod and polyinosinic–polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine
por: Zhou, Chun-Xue, et al.
Publicado: (2014)

The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm
por: Ghimire, Tirth Raj
Publicado: (2015)

Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation
por: Cerofolini, Linda, et al.
Publicado: (2019)

Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
por: McAdams, David, et al.
Publicado: (2021)

Sedimentation behavior of quality and freeze-damaged aluminum-adjuvanted vaccines by wNMR
por: Briggs, Katharine T., et al.
Publicado: (2023)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Distinctive cellular response to aluminum based adjuvants
por: Nies, Isaac, et al.
Publicado: (2020)

Modulation of Skin Inflammatory Responses by Aluminum Adjuvant
por: Liao, Yanhang, et al.
Publicado: (2023)

Effect of Autoclaving on the Physicochemical Properties and Biological Activity of Aluminum Oxyhydroxide Used as an Adjuvant in Vaccines
por: Skiba, Mohamed, et al.
Publicado: (2023)

Evaluation of precipitation time of the aluminum salts adsorbed potentially frozen vaccines used in the Polish National Immunization Schedule for their pre-qualification before the administration
por: Górska, Paulina, et al.
Publicado: (2022)

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
por: Fox, Christopher B., et al.
Publicado: (2012)

Near-Infrared Laser Adjuvant for Influenza Vaccine
por: Kashiwagi, Satoshi, et al.
Publicado: (2013)

Injectable Excipients as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Food Additives as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Promising Adjuvants and Platforms for Influenza Vaccine Development
por: Zhu, Wandi, et al.
Publicado: (2021)

Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities
por: Griffin, Marie R., et al.
Publicado: (2011)

Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
por: HogenEsch, Harm, et al.
Publicado: (2018)

Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools
por: Mei, Carmen, et al.
Publicado: (2019)

Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine–induced adverse events
por: Matsumura, Noriomi, et al.
Publicado: (2023)

Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks
por: Liu, Chun G, et al.
Publicado: (2011)

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
por: Kumru, Ozan S., et al.
Publicado: (2023)

Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
por: Orr, Mark T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_25u00ld9bs7qpom7n42hcjklao